Flonase and Heparin lock flush drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Flonase (fluticasone propionate) and Heparin lock flush (heparin sodium). Common drug interactions include oral herpes among females and pneumonia among males.

The phase IV clinical study analyzes what interactions people have when they take Flonase and Heparin lock flush. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Flonase?

Flonase has active ingredients of fluticasone propionate. It is often used in allergies. eHealthMe is studying from 75,441 Flonase users. Check the latest studies of Flonase.

What is Heparin lock flush?

Heparin lock flush has active ingredients of heparin sodium. eHealthMe is studying from 750 Heparin lock flush users. Check the latest studies of Heparin lock flush.



On Jul, 23, 2026

21 people who take Flonase and Heparin lock flush together, and have interactions are studied.

Flonase and Heparin lock flush drug interactions.

What are the common drug interactions of Flonase and Heparin Lock Flush, by gender? *:

female:

  1. Oral herpes (viral infection of mouth)
  2. Fluid overload (too much fluid in the blood)
  3. Septic shock (shock due to blood infection)
  4. Eye infection
  5. Eye irritation
  6. Aortic disorder
  7. Aphasia (damage to the parts of the brain that control language)
  8. Appendicitis (inflammation of the appendix)
  9. Blood pressure increased
  10. Carotid arterial embolus (obstruction in carotid artery)

male:

  1. Pneumonia
  2. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  3. Drug resistance (reduction in effectiveness of a drug)
  4. Hypoxia (low oxygen in tissues)
  5. Infection
  6. White blood cell count decreased

What are the common drug interactions of Flonase and Heparin Lock Flush, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Infection

20-29:

n/a

30-39:

  1. Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)
  2. Viral infection

40-49:

  1. Dacryostenosis acquired (obstruction of the nasolacrimal duct-acquired)
  2. Lacrimation increased
  3. Aortic disorder
  4. Aphasia (damage to the parts of the brain that control language)
  5. Blood pressure increased
  6. Carotid arterial embolus (obstruction in carotid artery)
  7. Carpal tunnel syndrome (nerve compression at wrist results numbness weakness, pain , swelling)
  8. Central nervous system lesion (an abnormality in tissue of brain or spinal cord)
  9. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  10. Demyelination (loss of the myelin covering of some nerve fibres resulting in their impaired function)

50-59:

  1. Eye infection
  2. Eye irritation
  3. Oral herpes (viral infection of mouth)
  4. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  5. Hypoxia (low oxygen in tissues)
  6. Pneumonia
  7. Pruritus (severe itching of the skin)
  8. Rash
  9. Urticaria (rash of round, red welts on the skin that itch intensely)
  10. Enterobacter bacteraemia (enterobacter cloacae are nosocomial pathogens that can cause a range of infections such as bacteraemia, lower respiratory tract infection, skin)

60+:

  1. Appendicitis (inflammation of the appendix)
  2. Drug resistance (reduction in effectiveness of a drug)
  3. Hospitalisation
  4. Pneumonia
  5. Sepsis (a severe blood infection that can lead to organ failure and death)
  6. White blood cell count decreased

What are the existing conditions these people have? *

  1. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 3 people, 14.29%
  2. Asthma: 3 people, 14.29%
  3. Nausea (feeling of having an urge to vomit): 2 people, 9.52%
  4. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 2 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take Flonase and Heparin lock flush?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Flonase and Heparin lock flush:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Flonase:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Heparin lock flush:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Flonase and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Heparin lock flush and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on fluticasone propionate and heparin sodium (the active ingredients of Flonase and Heparin lock flush, respectively), and Flonase and Heparin lock flush (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: